Filter
1974
Filtered Results: 1974
Text search:
and
A.
Rouse
Featured
Recommendations
289
New Publications
417
Language
Document type
No document type
591
Guidelines
469
Studies & Reports
429
Manuals
236
Strategic & Response Plan
119
Training Material
70
Fact sheets
37
Situation Updates
7
Infographics
7
Resource Platforms
5
Brochures
3
Videos
1
Countries / Regions
Global
151
India
69
Latin America and the Carribbean
39
Kenya
33
Western and Central Europe
33
Liberia
32
South–East Asia Region
29
Sierra Leone
27
Ukraine
26
Nigeria
26
Africa
25
Rwanda
21
Eastern Europe and Central Asia
21
South Africa
20
Ethiopia
20
Ghana
17
Uganda
17
Myanmar / Burma
16
Philippines
15
Tanzania
14
Bangladesh
14
Syria
13
Nepal
12
Middle East and North Africa
12
Asia
11
West and Central Africa
11
South Sudan
11
Guinea
10
Congo, Democratic Republic of
10
East and Southern Africa
10
Western Pacific Region
9
Malawi
7
Haiti
7
Yemen
7
Afghanistan
6
Russia
6
Pakistan
6
Jordan
5
Sudan
5
Zambia
5
Somalia
5
Tajikistan
4
Thailand
4
Senegal
4
Cambodia
4
North America
4
Lebanon
4
Eastern Europe
4
Iraq
4
North Macedonia
3
Timor Leste/ East Timor
3
Cameroon
3
Iran
3
Burkina Faso
3
Mozambique
3
Venezuela
3
Côte d’Ivoire / Ivory Coast
3
Namibia
3
Egypt
3
Colombia
2
Lesotho
2
Turkey
2
Kazakhstan
2
Laos
2
Kyrgyzstan
2
Peru
2
Zimbabwe
2
USA
2
Saudi Arabia
2
Vietnam
2
Djibouti
2
Georgia
2
Mali
2
Botswana
2
Indonesia
2
Ecuador
2
Eswatini/ Swaziland
2
North Korea
1
Serbia
1
Benin
1
China
1
Chile
1
Albania
1
Singapore
1
Estonia
1
Uzbekistan
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Armenia
1
Germany
1
Ireland
1
Paraguay
1
Denmark
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Belarus
1
French Guyana
1
Bolivia
1
Brazil
1
Sri Lanka
1
Greece
1
Palestine
1
Angola
1
Chad
1
Libya
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
423
Clinical Guidelines
268
Public Health
192
Key Resources
190
Women & Child Health
154
Capacity Building
63
Pharmacy & Technologies
57
Toolboxes
COVID-19
211
Mental Health
135
HIV
133
Caregiver
119
Planetary Health
118
TB
111
Rapid Response
93
NTDs
93
AMR
87
Ebola & Marburg
79
Pharmacy
55
Global Health Education
53
NCDs
49
Disability
41
Conflict
40
Natural Hazards
31
Refugee
23
Health Financing Toolbox
23
Cholera
11
Specific Hazards
9
Malaria
8
Polio
8
Zika
5
Social Ethics
2
Update 2021; Immunization, Vaccines and Biologicals
This new guideline on non-clinical interventions to reduce unnecessary caesarean sections incorporates the views, fears and beliefs of both women and health professionals about caesarean sections. It also considers the complex dynamics and limitations of health systems and organizations and relation...
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most of these diseases and conditions are at least partially cau...
Guidelines on the management of chronic pain in children, developing and implementing national and local policies for pain management and protocols in children, implementing national and local regulations for pain management in children, pain management and protocols
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
Many of the countries in the European Region receiving refugees from Ukraine are already offering vaccination services to children and adults. This is important to mitigate the risk of COVID-19 transmission among people travelling or living in close quarters, to protect the refugees from diseases th...
This guideline provides evidence-informed guidance on the use of non-sugar sweeteners to reduce the risk of unhealthy weight gain and diet-related noncommunicable diseases in adults and children. The guidance in this guideline is not based on toxicological assessments of the safety of individual no...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and adolescents taking both dolutegravir and non-dolutegravir based regimens.
Results are used to inform A...
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...
This study was carried out to better understand the local beliefs and practices likely to enhance or hinder efforts to respond to the Ebola Virus Disease outbreak in Liberia.
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Guidelines for the treatment of human African trypanosomiasis. Web Annex A. Commissioned by WHO Cochrane Response
This document aims to provide concrete, pragmatic guidance for how TB modelling and related technical assistance is undertaken to support country decision-making. The target audience for this document are the participants and stakeholders in country-level TB modelling efforts, including the individu...
Traditional food markets play important economic, cultural, and social role and are sources of livelihood for millions of people in urban and rural areas. The manual Five keys for safer traditional food markets: risk mitigation in traditional food markets in the Asia-Pacific Region aims to support a...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
The document “Malaria Elimination Programme Review, India 2022”, published by the WHO Country Office for India, provides an in-depth assessment of India’s progress toward malaria elimination. It evaluates the structure, implementation, and effectiveness of national and subnational malaria prog...
WHO recommendations on adolescent health: guidelines approved by the WHO Guidelines Review Committee
This document is meant to respond to the questions:
■ What health interventions should the adolescent receive and when should s/he receive it?
■ What health behaviours should the adolescent practise (or not practise)?
■ What health interventions should the adolescent receive and when should s/he receive it?
■ What health behaviours should the adolescent practise (or not practise)?
